In the hematopoietic system, NUP98-HOXA9, an oncogenic partner of Meis1 in human myeloid leukemia, has also been shown to promote symmetric self-renewal of hematopoietic precursors [44]. Here, HOXA9 is linked to myeloid leukemia.